PEREGRINE CAPITAL MANAGEMENT LLC
Position in PRAX — Praxis Precision Medicines, Inc.
CIK 764529
MINNEAPOLIS, MN
Position in PRAX
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$8,634,234
New position
Shares Held
25,790
first reported quarter
Ownership
0.092%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#97
of 309 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 37%
Shared 0%
None 63%
Position in Biotechnology
Healthcare · as of Jun 30, 2026PEREGRINE CAPITAL MANAGEMENT LLC holds $180,703,045 across 20 Biotechnology names. PRAX ranks #8 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
29,732 | $27,584,457 | |
| 2 | TWST |
Twist Bioscience Corp
|
138,970 | $14,297,233 | |
| 3 | MIRM |
Mirum Pharmaceuticals, Inc.
|
88,820 | $10,398,157 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
164,894 | $9,953,001 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
162,714 | $9,310,495 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
37,285 | $9,126,249 | |
| 7 | COGT |
Cogent Biosciences, Inc.
|
226,350 | $8,759,745 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
This page
|
25,790 | $8,634,234 |
All Filings in PRAX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,634,234 | 25,790 | Shares | Sole | 2026-07-17 | |
| No filing history on record for this holder in this stock. | ||||||